Targeting Tn5 transposase identifies human immunodeficiency virus type 1 inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 2035-2043

  Ason, Brandon ^a,d   Knauss, Daniel J ^b   Balke, Allison M ^a   Merkel, George ^c   Skalka, Anna Marie ^c   Reznikoff, William S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; CINNAMALDEHYDE; CINNAMOYL DERIVATIVE; COUMARIN; INTEGRASE INHIBITOR; TRANSPOSASE; TRANSPOSASE TN5; UNCLASSIFIED DRUG;

ARTICLE; CROSS REACTION; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME SPECIFICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN INTERACTION; PROTEIN TARGETING; VIRUS INHIBITION;

ANTI-HIV AGENTS; CELL SURVIVAL; CROSS REACTIONS; DNA, VIRAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; MODELS, MOLECULAR; PEPTIDE LIBRARY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSDUCTION, GENETIC; TRANSPOSASES;

EID: 18244375843     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.2035-2043.2005     Document Type: Article

References (43)

1. Artico, M., R. Di Santo, R. Costi, E. Novellino, G. Greco, S. Massa, E. Tramontano, M. E. Marongiu, A. De Montis, and P. La Colla. 1998. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: syrthesis, biological evaluation, and molecular modeling. J. Med. Chem. 41:2948-3960.
2. Asante-Appiah, E., and A. M. Skalka. 1997. Molecular mechanisms in retrovirus DNA integration. Antiviral Res. 36:139-156.
3. Ason, B., and W. S. Reznikoff 2004. DNA sequence bias during Tn5 transposition. J. Mol. Biol. 335:1213-1225.
4. Berg, D. E., and M. M. Howe (ed.). 1989. Mobile DNA, 1st ed. American Society for Microbiology, Washington, D.C.
5. Billich, A. 2003. S-1360 Shicnogi-GlaxoSmithKline. Curr. Opin. Investig. Drugs 4:206-209.
6. Bujacz, G., M. Jaskolski, J. Alexandratos, A. Wlodawer, G. Merkel, R. A. Katz, and A. M. Skalka. 1996. The catalytic domain of avian sarcoma virus integrase: conformation of the active-site residues in the presence of divalent cations. Structure 4:89-96.
7. Bujacz, G., M. Jaskolski, J. Alexandratos, A. Wlodawer, G. Merkel, R. A. Katz, and A. M. Skalka. 1995. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253:333-346.
8. Burke, T. R., Jr., M. R. Fesen, A. Mazumder, J. Wang, A. M. Carothers, D. Grunberger, J. Driscoll, K. Kohn, and Y. Pommier. 1995. Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem. 38:4171-4178.
9. Chen, J. C., J. Krucinski, L. J. Miercke, J. S. Finer-Moore, A. H. Tang, A. D. Leavitt, and R. M. Stroud. 2000. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. USA 97:8233-8238.
10. Chiu, T. K., and D. R. Davies. 2004. Structure and function of HIV-1 integrase. Curr. Top. Med. Chem. 4:965-977.
11. Coffin, J. M., S. H. Hughes, and H. E. Varmus. 1997. The retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
12. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mono-nuclear phagocytes. Virology 206:935-944.
13. Craig, N. L., R. C., M. Gellert, and A. M. Lambowitz (ed.). 2002. Mobile DNA II. ASM Press, Washington, D.C.
14. Daniel, R., C. B. Myers, J. Kulkosky, K. Taganov, J. G. Greger, G. Merkel, I. T. Weber, R. W. Harrison, and A. M. Skalka. 2004. Characterization of a naphthalene derivative inhibitor of retroviral integrases. AIDS Res. Hum. Retrovir. 20:135-144.
15. Davies, D. R., L. M. Braam W. S. Reznikoff, and I. Rayment. 1999. The three-dimensional structure of a Tn5 transposase-related protein determined to 2.9-A resolution. J. Biol. Chem. 274:11904-11913.
16. Davies, D. R., I. Y. Goryshin, W. S. Reznikoff, and I. Rayment. 2000. Three-dimensional structure of the Tn5 synaptic complex transposition intermediate. Science 289:77-85.
17. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
18. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266:1981-1986.
19. Esposito, D., and R. Craigie. 1999. HIV integrase structure and function. Adv. Virus Res. 52:319-333.
20. Farnet, C. M., B. Wang, J. R. Lipford, and F. D. Bushman. 1996. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc. Natl. Acad. Sci. USA 93:9742-9747.
21. Goldgur, Y., R. Craigie, G. H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D. R. Davies. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA 96:13040-13043.
22. Goldgur, Y., F. Dyda, A. B. Hickman, T. M. Jenkins, R. Craigie, and D. R. Davies. 1998. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA 95:9150-9154.
23. Harger, J. W., and J. D. Dinman. 2003. An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. RNA 9:1019-1024.
24. Hazuda, D, J., P. Felock, M. Witmer, A. Wolfe, K. Stillmock, J. A. Grobler, A. Espeseth, L. Gabryelski, W. Schleif, C. Blau, and M. D. Miller. 2000. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287:646-650.
25. Hazuda, D. J., S. D. Young, J. P. Guare, N. J. Anthony, R. P. Gomez, J. S. Wai, J. P. Vacca, L. Handt, S. L. Motzel, H. J. Klein, G. Dornadula, R. M. Danovich, M. V. Witmer, K. A. Wilson, L. Tussey, W. A. Schleif, L. S. Gabryelski, L. Jin, M. D. Miller, D. R. Casimiro, E. A. Emini, and J. W. Shiver. 2004. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques. Science 305:528-532. (First published 8 July 2004; doi:10.1126/science.1098632).
26. 2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:6705-6711.
27. Lubkowski, J., F. Yang, J. Alexandratos, A. Wlodawer, H. Zhao, T. R. Burke, Jr., N. Neamati, Y. Pommier, G. Merkel, and A. M. Skalka. 1998. Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proc. Natl. Acad. Sci. USA 95:4831-4836.
28. Maignan, S., J. P. Guilloteau, Q. Zhou-Liu, C. Clement-Mella, and V. Mikol. 1998. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J. Mol. Biol. 282:359-368.
29. Mao, P. C., J. F. Mouscadet, H. Leh, C. Auclair, and L. Y. Hsu. 2002. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity. Chem. Pharm. Bull. (Tokyo) 50:1634-1637.
30. Morner, A., A. Bjorndal, J. Albert, V. N. Kewalramani, D. R. Littman, R. Inoue, R. Thorstensson, E. M. Fenyo, and E. Bjorling. 1999. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J. Virol. 73: 2343-2349.
31. Naumann, T. A., and W. S. Reznikoff. 2002. Tn5 transposase active site mutants. J. Biol. Chem. 277:17623-17629.
32. Naumann, T. A., and W. S. Reznikoff. 2000. Trans catalysis in Tn5 transposition. Proc. Natl. Acad. Sci. USA 97:8944-8949.
33. Nissley, D. V., P. L. Boyer, D. J. Garfinkel, S. H. Hughes, and J. N. Strathern. 1998. Hybrid Ty1/HIV-1 elements used to detect inhibitors and monitor the activity of HIV-1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 95:13905-13910.
34. Pluymers, W., E. De Clercq, and Z. Debyser. 2001. HIV-1 integration as a target for antiretroviral therapy: a review. Curr. Drug Targets Infect. Disord. 1:133-149.
35. Pluymers, W., N. Neamati, C. Pannecouque, V. Fikkert, C. Marchand, T. R. Burke, Jr., Y. Pommier, D. Schols, E. De Clercq, Z. Debyser, and M. Witvrouw. 2000. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Mol. Pharmacol. 58:641-648.
36. Rice, P. A., and T. A. Baker. 2001. Comparative architecture of transposase and integrase complexes. Nat. Struct. Biol. 8:302-307.
37. Sarnovsky, R. J., E. W. May, and N. L. Craig. 1996. The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products. EMBO J. 15:6348-6361.
38. Taganov, K. D., I. Cuesta, R. Daniel, L. A. Cirillo, R. A. Katz, K. S. Zaret, and A. M. Skalka. 2004. Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro. J. Virol. 78:5848-5855.
39. van Gent, D. C., K. Mizuuchi, and M. Gellert. 1996. Similarities between initiation of V(D)J recombination and retroviral integration. Science 271: 1592-1594.
40. Wang, J. Y., H. Ling, W. Yang, and R. Craigie. 2001. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J. 20:7333-7343.
41. Williams, T. L., E. L. Jackson, A. Carritte, and T. A. Baker. 1999. Organization and dynamics of the Mu transpososome: recombination by communication between two active sites. Genes Dev. 13:2725-2737.
42. Yang, Z. N., T. C. Mueser, F. D. Bushman, and C. C. Hyde. 2000. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. J. Mol. Biol. 296:535-548.
43. Zhao, H., N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, G. W. Milne, Y. Pommier, and T. R. Burke, Jr. 1997. Coumarin-based inhibitors of HIV integrase. J. Med. Chem. 40:242-249.